X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (938) 938
phenylpropionates - therapeutic use (851) 851
male (694) 694
female (605) 605
middle aged (444) 444
adult (413) 413
animals (375) 375
aged (304) 304
phenylpropionates - pharmacology (276) 276
clinical trials as topic (268) 268
double-blind method (217) 217
pharmacology & pharmacy (182) 182
phenylpropionates - adverse effects (179) 179
rats (177) 177
ketoprofen - therapeutic use (149) 149
phenylpropionates - administration & dosage (139) 139
arthritis, rheumatoid - drug therapy (126) 126
anti-inflammatory agents, non-steroidal - therapeutic use (125) 125
mice (125) 125
hypertension, pulmonary - drug therapy (122) 122
pyridazines - therapeutic use (120) 120
adolescent (111) 111
time factors (111) 111
treatment outcome (105) 105
endothelin receptor antagonists (103) 103
dose-response relationship, drug (102) 102
pain - drug therapy (91) 91
antihypertensive agents - therapeutic use (85) 85
aspirin - therapeutic use (82) 82
drug evaluation (82) 82
anti-inflammatory agents - therapeutic use (80) 80
osteoarthritis - drug therapy (80) 80
pyrimidines - therapeutic use (80) 80
random allocation (80) 80
indoprofen - therapeutic use (71) 71
endothelin (69) 69
phenylpropionates - chemistry (69) 69
drug therapy, combination (68) 68
pain, postoperative - drug therapy (68) 68
ibuprofen - therapeutic use (66) 66
pulmonary hypertension (65) 65
indomethacin - therapeutic use (63) 63
sulfonamides - therapeutic use (63) 63
suprofen - therapeutic use (63) 63
administration, oral (62) 62
bosentan (62) 62
ambrisentan (61) 61
placebos (61) 61
fenoprofen - therapeutic use (58) 58
therapy (58) 58
phenylpropionates - pharmacokinetics (55) 55
hypertension (52) 52
ketoprofen - adverse effects (50) 50
analysis (47) 47
cardiac & cardiovascular systems (47) 47
chemistry, medicinal (46) 46
ppar gamma - agonists (46) 46
research (46) 46
disease models, animal (45) 45
phenylpropionates - metabolism (44) 44
endothelin a receptor antagonists (43) 43
ketoprofen - administration & dosage (43) 43
drug therapy (42) 42
hypertension, pulmonary - physiopathology (42) 42
rats, sprague-dawley (42) 42
ppar alpha - agonists (41) 41
pyrimidines - pharmacology (41) 41
drug interactions (40) 40
medicine, research & experimental (40) 40
pulmonary arterial hypertension (40) 40
rheumatic diseases - drug therapy (40) 40
blood pressure - drug effects (39) 39
diabetes mellitus, type 2 - drug therapy (39) 39
expression (39) 39
metabolism (39) 39
pyridazines - adverse effects (39) 39
survival (39) 39
child (38) 38
suprofen - adverse effects (38) 38
aspirin - adverse effects (37) 37
care and treatment (37) 37
mice, inbred c57bl (37) 37
rats, wistar (37) 37
anti-inflammatory agents, non-steroidal - adverse effects (36) 36
medicine, general & internal (36) 36
pyridazines - pharmacology (36) 36
receptor, endothelin a (36) 36
young adult (36) 36
respiratory system (35) 35
abridged index medicus (34) 34
biochemistry & molecular biology (34) 34
double-blind (34) 34
inflammation (34) 34
pyridazines - administration & dosage (34) 34
aged, 80 and over (33) 33
analgesics - therapeutic use (33) 33
ibuprofen - adverse effects (33) 33
thiophenes - therapeutic use (33) 33
antihypertensive agents - adverse effects (31) 31
insulin resistance (31) 31
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1012) 1012
French (56) 56
Japanese (46) 46
Italian (44) 44
German (33) 33
Russian (33) 33
Chinese (10) 10
Polish (10) 10
Spanish (10) 10
Czech (4) 4
Dutch (3) 3
Bulgarian (2) 2
Danish (2) 2
Norwegian (2) 2
Swedish (2) 2
Croatian (1) 1
Hebrew (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 03/2016, Volume 149, Issue 3, pp. 756 - 766
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 9, pp. 834 - 844
Journal Article
Seminars in Respiratory and Critical Care Medicine, ISSN 1069-3424, 10/2013, Volume 34, Issue 5, pp. 560 - 567
Journal Article
Chest, ISSN 0012-3692, 2009, Volume 135, Issue 1, pp. 122 - 129
Background: Some endothelin receptor antagonists (ERAs) are associated with liver function test (LFT) result abnormalities. However, ambrisentan has an... 
Liver function test | Bosentan | Sulfonamide | Endothelin receptor antagonist | Serum aminotransferase | Hepatotoxicity | Propanoic acid | Pulmonary hypertension | Ambrisentan | Sitaxsentan | SURVIVAL | CONTROLLED-TRIAL | EFFICACY | ATRASENTAN | SAFETY | ambrisentan | propanoic acid | pulmonary hypertension | sitaxsentan | serum aminotransferase | ENDOTHELIN ANTAGONIST BOSENTAN | liver function test | RECEPTOR ANTAGONIST | REFRACTORY PROSTATE-CANCER | bosentan | sulfonamide | RESPIRATORY SYSTEM | hepatotoxicity | MEN | endothelin receptor antagonist | BLOCKADE | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Male | Young Adult | Phenylpropionates - therapeutic use | Adult | Female | Hypertension, Pulmonary - drug therapy | Child | Endothelin Receptor Antagonists | Hypertension, Pulmonary - enzymology | Pyridazines - therapeutic use | Liver Function Tests | Treatment Outcome | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Disease-Free Survival | Sulfonamides - therapeutic use | Adolescent | Sulfonamides - adverse effects | Transaminases - blood | Aged | Isoxazoles - therapeutic use | Isoxazoles - adverse effects | Complications and side effects | Analysis | Dosage and administration | Research | Drug therapy | Liver function tests | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 1, pp. 20 - 26
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 164, Issue 5, pp. 672 - 680
Journal Article
British journal of haematology, ISSN 1365-2141, 12/2009, Volume 147, Issue 5, pp. 737 - 743
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2017, Volume 126, pp. 84 - 92
... with fewer clinical worsening events and improved survival have been reported [1]. Current therapeutic options target one of three abnormal pathways identified in PAH... 
Pulmonary/Respiratory | Phosphodiesterase 5 inhibitor | Pulmonary Hypertension | Endothelin A receptor antagonist | Outcome assessment | Combination drug therapy | Ambrisentan | 5 INHIBITOR THERAPY | CARDIAC & CARDIOVASCULAR SYSTEMS | SILDENAFIL | METAANALYSIS | SAFETY | RANDOMIZED CONTROLLED-TRIAL | TADALAFIL | COMBINATION | ENDOTHELIN RECEPTOR ANTAGONIST | RESPIRATORY SYSTEM | ORAL TREPROSTINIL | BOSENTAN | Hypertension, Pulmonary - classification | Outcome Assessment (Health Care) | Humans | Middle Aged | Hypertension, Pulmonary - physiopathology | Male | Pyridazines - pharmacology | Exercise Tolerance - drug effects | Dose-Response Relationship, Drug | Tadalafil - administration & dosage | Natriuretic Peptide, C-Type - drug effects | Pyridazines - administration & dosage | Tadalafil - pharmacology | Adult | Female | Phenylpropionates - adverse effects | Hypertension, Pulmonary - drug therapy | Phosphodiesterase 5 Inhibitors - therapeutic use | Endothelin A Receptor Antagonists - therapeutic use | Pyridazines - adverse effects | Biomarkers - metabolism | Phenylpropionates - administration & dosage | Treatment Outcome | Antihypertensive Agents - therapeutic use | Survival | Phenylpropionates - pharmacology | Drug Therapy, Combination - methods | Elapid Venoms | Hemodynamics - drug effects | Medical colleges | Medical research | Care and treatment | Medicine, Experimental | Cardiology | Health aspects | Pulmonary hypertension | Complications and side effects | Endothelin | Drug therapy, Combination | Heart | Therapy | Chest | Physical training | Target recognition | Syngeneic grafts | Liver | pH effects | Incidence | Design | Connective tissues | Blood pressure | Diagnosis | Pulmonary arteries | Cut-off | Mortality | Committees | Frost | Physical fitness | Inhibitors | Blood circulation | Nitric oxide | Capillary pressure | Death | Toxins | Hemodynamics | Liver transplantation | Drugs | Diastolic pressure | Clinical trials | Clinical outcomes | Contraction | Arteries | Guidelines | Ethics | Dyspnea | Safety | Drug therapy | Heart diseases | Age | Hypertension | Brain natriuretic peptide | Receiving | Effectiveness | Statistical analysis | Pharmacology | Adhesion | Coronary artery disease | Nickel | Ventricle | Pharmacokinetics | Respiration
Journal Article
Journal Article